Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.0K
Overview
46.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigens.

Nature·2026
Same author

Maternal microchimerism at birth associates with reduced odds of non-malarial fever and respiratory tract infections in Tanzanian children.

PLOS global public health·2026
Same author

Mosquito direct skin feeding bioassay: 15 years of experience and a standardised approach in Mali.

Malaria journal·2026
Same author

Antibody levels to variant and conserved <i>Plasmodium falciparum</i> antigens predict reduction in parasite burden in Malian children.

Frontiers in immunology·2026
Same author

Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.

The Lancet. Microbe·2026
Same author

Epitope-specific competitive ELISA predicts malaria transmission-blocking vaccine Pfs230D1 activity measured in standard membrane feeding assay.

JCI insight·2026

Related Experiment Video

Updated: Oct 11, 2025

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.3K

Making a good malaria vaccine better.

Patrick E Duffy1

  • 1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Trends in Parasitology
|December 3, 2021
PubMed
Summary

The World Health Organization recommends the RTS,S/AS01 vaccine for children in Africa to prevent severe malaria. New research explores how antibody functions contribute to the vaccine's effectiveness, aiding future improvements.

Keywords:
RTS,Sfractional regimenmalariasystems serologyvaccine

More Related Videos

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
10:27

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

Published on: November 10, 2015

11.8K

Related Experiment Videos

Last Updated: Oct 11, 2025

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.3K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
10:27

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

Published on: November 10, 2015

11.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • The World Health Organization recently recommended the RTS,S/AS01 malaria vaccine for widespread use in children.
  • This vaccine has demonstrated a 30% reduction in severe malaria cases among young African children.
  • Understanding the mechanisms of RTS,S/AS01 vaccine efficacy is crucial for further development.

Purpose of the Study:

  • To investigate the specific antibody effector functions elicited by the RTS,S/AS01 vaccine.
  • To determine how these antibody functions contribute to the observed protection against severe malaria.
  • To provide insights for the rational design of improved malaria vaccines.

Main Methods:

  • Analysis of antibody responses in individuals vaccinated with RTS,S/AS01.
  • Assessment of various antibody effector functions, such as antibody-dependent cellular cytotoxicity (ADCC) and complement deposition.
  • Correlation of specific antibody profiles with protection against malaria.

Main Results:

  • The study identified distinct antibody effector functions associated with RTS,S/AS01 vaccination.
  • Specific antibody responses were linked to reduced risk of severe malaria.
  • These findings highlight the importance of functional antibodies in vaccine-induced immunity.

Conclusions:

  • Antibody effector functions play a significant role in the efficacy of the RTS,S/AS01 malaria vaccine.
  • Targeting and enhancing these functions could lead to next-generation malaria vaccines with improved efficacy.
  • Further research into antibody-mediated immunity is essential for malaria control efforts.